Sentiment-Signal
Score-Verlauf (90 Tage)
Stammdaten
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
Unternehmen & Branche
| Name | Arcutis Biotherapeutics, Inc. |
|---|---|
| Ticker | ARQT |
| CIK | 0001787306 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 2,79 Mrd. USD |
| Beta | 1,77 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 376,072,000 | -16,141,000 | -0.13 | 432,973,000 | 189,479,000 |
| 2025-09-30 | 10-Q | 99,219,000 | 7,410,000 | 0.06 | 370,977,000 | 158,073,000 |
| 2025-06-30 | 10-Q | 81,504,000 | -15,886,000 | -0.13 | 352,433,000 | 138,974,000 |
| 2025-03-31 | 10-Q | 65,846,000 | -25,060,000 | -0.20 | 344,105,000 | 142,658,000 |
| 2024-12-31 | 10-K | 196,542,000 | -140,039,000 | -1.16 | 348,889,000 | 157,541,000 |
| 2024-09-30 | 10-Q | 44,755,000 | -41,537,000 | -0.33 | 437,354,000 | 156,641,000 |
| 2024-06-30 | 10-Q | 30,858,000 | -52,332,000 | -0.42 | 444,759,000 | 186,427,000 |
| 2024-03-31 | 10-Q | 49,569,000 | -35,382,000 | -0.32 | 478,541,000 | 224,942,000 |
| 2023-12-31 | 10-K | 59,606,000 | -262,140,000 | -3.78 | 341,365,000 | 88,667,000 |
| 2023-09-30 | 10-Q | 38,109,000 | -44,765,000 | -0.73 | 292,959,000 | 46,717,000 |
| 2023-06-30 | 10-Q | 5,190,000 | -70,991,000 | -1.16 | 320,689,000 | 80,508,000 |
| 2023-03-31 | 10-Q | 2,781,000 | -80,100,000 | -1.31 | 379,458,000 | 139,732,000 |
| 2022-12-31 | 10-K | 3,686,000 | -311,458,000 | -5.66 | 449,274,000 | 209,581,000 |
| 2022-09-30 | 10-Q | -107,709,000 | -1.89 | 508,914,000 | 270,774,000 | |
| 2022-06-30 | 10-Q | 0 | -67,406,000 | -1.31 | 300,464,000 | 195,382,000 |
| 2022-03-31 | 10-Q | -64,324,000 | -1.27 | 364,109,000 | 253,772,000 | |
| 2021-12-31 | 10-K | -206,356,000 | -4.18 | 408,152,000 | 297,677,000 | |
| 2021-09-30 | 10-Q | -56,980,000 | -1.14 | 387,008,000 | 362,995,000 | |
| 2021-06-30 | 10-Q | -42,008,000 | -0.84 | 432,892,000 | 414,488,000 | |
| 2021-03-31 | 10-Q | -36,042,000 | -0.76 | 471,416,000 | 450,994,000 |
Fondsaktivität (Vorquartalsvergleich)
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | Leonard Keith R | Director | Open Market Sale | -39,272 | 25.39 | -997,194.62 | -482,2% | |
| 2025-12-15 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -11,500 | 28.94 | -332,851.40 | -160,9% | |
| 2025-12-01 | Welgus Howard G. | Director | Open Market Sale | -10,000 | 30.21 | -302,133.00 | -146,1% | |
| 2025-12-01 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -1,657 | 30.23 | -50,091.11 | -24,2% | |
| 2025-11-24 | LIN SUE-JEAN | Director | Open Market Sale | -25,272 | 30.78 | -777,955.56 | -376,2% | |
| 2025-11-24 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -48,945 | 30.36 | -1,485,754.84 | -718,4% | |
| 2025-11-21 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -1,055 | 30.00 | -31,650.00 | -15,3% | |
| 2025-11-20 | Gilbert Halley E | Director | Open Market Sale | -16,532 | 27.55 | -455,441.72 | -220,2% | |
| 2025-11-19 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -1,561 | 28.50 | -44,488.50 | -21,5% | |
| 2025-11-19 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -989 | 27.95 | -27,646.60 | -13,4% | |
| 2025-11-13 | Krishnamohan Neha | Director | Open Market Sale | -1,232 | 23.37 | -28,791.84 | -13,9% | |
| 2025-11-13 | Krishnamohan Neha | Director | Open Market Sale | -39,272 | 23.19 | -910,701.97 | -440,3% | |
| 2025-11-06 | Edwards Larry Todd | Officer, See Remarks | Open Market Sale | -29,131 | 25.16 | -732,927.22 | -354,4% | |
| 2025-11-06 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -17,250 | 24.18 | -417,144.68 | -201,7% | |
| 2025-11-05 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -3,864 | 23.72 | -91,643.26 | -44,3% | |
| 2025-11-03 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -15 | 25.40 | -381.00 | -0,2% | |
| 2025-11-03 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -7,165 | 24.71 | -177,063.63 | -85,6% | |
| 2025-11-03 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -43 | 25.40 | -1,092.14 | -0,5% | |
| 2025-11-03 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -11,478 | 24.71 | -283,646.63 | -137,2% | |
| 2025-11-03 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -69 | 25.40 | -1,752.54 | -0,8% | |
| 2025-11-03 | Vairavan Latha | Officer, SVP Chief Financial Officer | Open Market Sale | -88 | 24.72 | -2,175.23 | -1,1% | |
| 2025-11-03 | Welgus Howard G. | Director | Open Market Sale | -10,000 | 25.27 | -252,669.00 | -122,2% | |
| 2025-11-03 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -2,607 | 24.71 | -64,425.23 | -31,2% | |
| 2025-10-28 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -40,000 | 25.03 | -1,001,032.00 | -484,0% | |
| 2025-10-02 | Edwards Larry Todd | Officer, See Remarks | Open Market Sale | -297 | 20.78 | -6,171.69 | -3,0% | |
| 2025-10-02 | Edwards Larry Todd | Officer, See Remarks | Open Market Sale | -4,207 | 19.99 | -84,091.62 | -40,7% | |
| 2025-10-02 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -20,739 | 20.04 | -415,574.30 | -200,9% | |
| 2025-10-01 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -9,261 | 20.02 | -185,371.88 | -89,6% | |
| 2025-10-01 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -15,000 | 18.91 | -283,702.50 | -137,2% | |
| 2025-10-01 | Welgus Howard G. | Director | Open Market Sale | -462 | 18.92 | -8,742.29 | -4,2% | |
| 2025-10-01 | Welgus Howard G. | Director | Open Market Sale | -9,538 | 18.92 | -180,484.71 | -87,3% | |
| 2025-09-09 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -504 | 17.52 | -8,829.02 | -4,3% | |
| 2025-09-08 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -9,625 | 17.54 | -168,799.40 | -81,6% | |
| 2025-09-04 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -36,130 | 16.16 | -583,716.28 | -282,2% | |
| 2025-09-02 | Welgus Howard G. | Director | Open Market Sale | -10,000 | 15.64 | -156,383.00 | -75,6% | |
| 2025-08-21 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -2,438 | 15.57 | -37,968.92 | -18,4% | |
| 2025-08-19 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -1,750 | 16.16 | -28,280.70 | -13,7% | |
| 2025-08-08 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -3,847 | 14.03 | -53,988.41 | -26,1% | |
| 2025-08-04 | Watanabe Todd | Director, Officer, See Remarks | Open Market Sale | -11,547 | 14.33 | -165,429.25 | -80,0% | |
| 2025-08-04 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -6,330 | 14.33 | -90,687.38 | -43,8% | |
| 2025-08-04 | Vairavan Latha | Officer, SVP Chief Financial Officer | Open Market Sale | -89 | 14.33 | -1,275.07 | -0,6% | |
| 2025-08-04 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -2,622 | 14.33 | -37,564.35 | -18,2% | |
| 2025-08-01 | Welgus Howard G. | Director | Open Market Sale | -6,110 | 14.30 | -87,362.00 | -42,2% | |
| 2025-08-01 | Welgus Howard G. | Director | Open Market Sale | -3,890 | 14.30 | -55,620.00 | -26,9% | |
| 2025-07-14 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -5,750 | 15.07 | -86,653.65 | -41,9% | |
| 2025-07-10 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -23,000 | 15.05 | -346,046.50 | -167,3% | |
| 2025-07-01 | Welgus Howard G. | Director | Open Market Sale | -9,208 | 13.84 | -127,430.43 | -61,6% | |
| 2025-06-18 | Welgus Howard G. | Director | Open Market Sale | -10,139 | 13.37 | -135,573.64 | -65,6% | |
| 2025-06-13 | Heron Patrick J | Director | Open Market Purchase | 2,646 | 13.08 | 34,610.47 | +16,7% | |
| 2025-06-05 | Heron Patrick J | Director | Open Market Purchase | 378 | 13.41 | 5,069.28 | +2,5% | |
| 2025-06-04 | Heron Patrick J | Director | Open Market Purchase | 1,890 | 13.32 | 25,177.45 | +12,2% | |
| 2025-05-22 | Heron Patrick J | Director | Open Market Purchase | 2,520 | 13.65 | 34,398.00 | +16,6% | |
| 2025-05-21 | Heron Patrick J | Director | Open Market Purchase | 2,520 | 13.66 | 34,423.20 | +16,6% | |
| 2025-05-15 | Heron Patrick J | Director | Open Market Purchase | 2,520 | 13.62 | 34,316.86 | +16,6% | |
| 2025-05-14 | Heron Patrick J | Director | Open Market Purchase | 6,300 | 13.76 | 86,691.15 | +41,9% | |
| 2025-05-13 | Heron Patrick J | Director | Open Market Purchase | 2,374 | 13.76 | 32,660.78 | +15,8% | |
| 2025-05-09 | Heron Patrick J | Director | Open Market Purchase | 6,300 | 13.60 | 85,691.34 | +41,4% | |
| 2025-05-02 | Matsuda Masaru | Officer, See Remarks | Open Market Sale | -5,030 | 15.20 | -76,453.49 | -37,0% | |
| 2025-05-02 | Burnett Patrick | Officer, See Remarks | Open Market Sale | -2,597 | 15.19 | -39,442.46 | -19,1% | |
| 2025-05-02 | Watanabe Todd Franklin | Director, Officer, See Remarks | Open Market Sale | -11,448 | 15.19 | -173,916.87 | -84,1% | |
| 2025-05-01 | Welgus Howard G. | Director | Open Market Sale | -10,000 | 14.64 | -146,357.00 | -70,8% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.